Mateusz Kaczmarek

A technology and finance expert writing for TS2.tech. He analyzes developments in satellites, telecommunications, and artificial intelligence, with a focus on their impact on global markets. Author of industry reports and market commentary, often cited in tech and business media. Passionate about innovation and the digital economy.

Quoin Pharmaceuticals (QNRX) Soars After Hitting 4%/5% Topical Rapamycin Targets; Clinical Batches This Quarter, Human Trials 1H 2026 [Nov. 11, 2025]

Quoin Pharmaceuticals (QNRX) Soars After Hitting 4%/5% Topical Rapamycin Targets; Clinical Batches This Quarter, Human Trials 1H 2026 [Nov. 11, 2025]

What happened today Quoin Pharmaceuticals, Ltd. (NASDAQ: QNRX) announced that it has successfully achieved target loading concentrations for two topical rapamycin delivery technologies—4% in its lotion and 5% in a dermal patch. The company said it will start manufacturing clinical and stability batches this quarter and is planning clinical testing in the first half of 2026. Initial targets include MLM and VM, which currently lack any FDA‑approved treatments. GlobeNewswire Quoin’s topical rapamycin program is identified on its pipeline page as QRX009, a formulation designed to improve skin penetration and local delivery—an area the company says has limited the performance of
China’s Hongqi Bridge on G317 Partially Collapses in Sichuan After Slope Failure; No Injuries Reported (Nov. 11, 2025)

China’s Hongqi Bridge on G317 Partially Collapses in Sichuan After Slope Failure; No Injuries Reported (Nov. 11, 2025)

A section of the Hongqi Bridge on National Highway 317 in Maerkang, Sichuan province, partially collapsed on Tuesday following a mountain slope failure; local authorities said no casualties were reported. China Daily Police had already shut the 758‑meter bridge to all traffic on Monday after cracks and terrain shifts were detected nearby; worsening conditions on Tuesday triggered landslides that brought down approach spans and the roadbed, according to an official notice. Reuters The route forms part of a key overland link between China’s interior and Tibet, amplifying the regional transport impact of the disruption. Reuters Construction of the bridge was
11 November 2025
Paramount Skydance (NASDAQ: PSKY) Jumps on First Post‑Merger Earnings: $1.5B Content Push, $3B Cost Cuts, Paramount+ Price Hike — 11/11/2025

Paramount Skydance (NASDAQ: PSKY) Jumps on First Post‑Merger Earnings: $1.5B Content Push, $3B Cost Cuts, Paramount+ Price Hike — 11/11/2025

Paramount Skydance Corporation reported its first results since the Skydance–Paramount merger and the stock rallied after management laid out a bigger streaming-and-studios investment plan and raised its cost‑savings target. Shares were up ~5.5% today as CEO David Ellison emphasized a tech‑forward overhaul, a fatter content slate, and a sharper path to profitability. Reuters Quick take (today) What happened on November 11, 2025 Stock reaction & strategy. Investors bid PSKY higher after management raised its savings target to $3B, laid out >$1.5B in incremental 2026 programming investments, and reiterated a push to unify streaming platforms and ramp to ~15 theatrical releases
Lyft (LYFT) News Today: OVG venue deal goes national, LA taxi integration advances, and LYFT stock check — Nov. 11, 2025

Lyft (LYFT) News Today: OVG venue deal goes national, LA taxi integration advances, and LYFT stock check — Nov. 11, 2025

Lyft becomes the Official Rideshare Partner across 75+ Oak View Group venues serving ~65M fans a year, while its licensed‑taxi integration in Los Angeles gains fresh coverage. Here’s what it means for riders, venues, and investors—plus the LYFT price snapshot for today. Lyft becomes OVG’s rideshare partner across 75+ venues What’s new: Oak View Group and Lyft announced a multi‑year national partnership that makes Lyft the Official Rideshare Partner at more than 75 OVG‑managed and Alliance venues across the U.S. (including Arena Alliance and Theater Alliance members). OVG says these venues collectively draw ~65 million fans each year. Beyond naming
Kaltura (KLTR) soars as Q3 beats, $27M eSelf.ai deal lands, and 14.4M-share buyback headlines — Nov. 11, 2025

Kaltura (KLTR) soars as Q3 beats, $27M eSelf.ai deal lands, and 14.4M-share buyback headlines — Nov. 11, 2025

What’s new today (Nov. 11, 2025) Shares surge after Q3 + AI deal headlines. KLTR is one of today’s bigger software movers. Benzinga’s pre‑market screen flagged KLTR up ~26.5% to $1.86 before the bell following last night’s results and acquisition news; live prices show the rally continuing after the open. Benzinga Local tech press amplifies the acquisition. Israeli outlet CTech detailed the $27M structure (including 4.69M Kaltura shares vesting over three years—about 3% of pre‑deal share base) and reiterated that closing is targeted for Q4 2025, pending approvals. TechCrunch highlighted co‑founder Dr. Alan Bekker’s prior sale of Voca.ai to Snap
Aspire Biopharma (ASBP) Whipsaws on Heavy Volume Today as Investors Eye Reverse‑Split Authority and Nasdaq Compliance — Nov. 11, 2025

Aspire Biopharma (ASBP) Whipsaws on Heavy Volume Today as Investors Eye Reverse‑Split Authority and Nasdaq Compliance — Nov. 11, 2025

What moved ASBP today (Nov. 11) Trading in Aspire Biopharma swung sharply. A pre‑market “health‑care movers” screen showed ASBP briefly up more than 30%, before regular‑session selling pulled shares lower on very heavy volume. Mid‑session, ASBP was down roughly 20–25% versus Monday’s close, with an exceptionally wide intraday range—characteristic of micro‑cap names facing near‑term listing and financing milestones. Benzinga While price action is noisy, there were no fresh corporate announcements today. The latest company communication remains last week’s trade‑show recap from CPHI Frankfurt, where Aspire says it held 16 formal meetings and multiple informal conversations with global pharmas regarding potential
Endava (DAVA) Sinks After Q1 FY26 Miss; FY26 Outlook Trimmed as Company Expands TRD U.S.A. Partnership — Nov 11, 2025

Endava (DAVA) Sinks After Q1 FY26 Miss; FY26 Outlook Trimmed as Company Expands TRD U.S.A. Partnership — Nov 11, 2025

Endava plc (NYSE: DAVA) reported weaker‑than‑expected first‑quarter fiscal 2026 results before the U.S. market open today and cut its full‑year guidance. Shares fell sharply in early trading as investors digested a year‑over‑year revenue decline and softer outlook; the company also announced an expanded multi‑year partnership with Toyota Racing Development (TRD U.S.A.). Business Wire+3Business Wire+3MarketWatch+3 Quick takeaways By the numbers: Q1 FY26 (quarter ended Sept 30, 2025) Business mix & clients. Endava ended the quarter with 11,636 total headcount; 133 clients generated over £1M on a rolling‑12‑month basis. Revenue mix: North America 42%, UK 28%, Europe 24%, RoW 6%. By industry:
ZenaTech (ZENA) Q3: Revenue Jumps 1,225% as Drone‑as‑a‑Service Scales — All the News Today (Nov. 11, 2025)

ZenaTech (ZENA) Q3: Revenue Jumps 1,225% as Drone‑as‑a‑Service Scales — All the News Today (Nov. 11, 2025)

ZenaTech, Inc. (NASDAQ: ZENA; FSE: 49Q; BMV: ZENA) reported record third‑quarter results this morning, led by a surge in Drone‑as‑a‑Service (DaaS) revenue and continued expansion via acquisitions. Financial outlets picked up the release across the day, while filings show the company furnished unaudited nine‑month financials to the SEC. Here’s everything published today, Nov. 11, 2025, plus what it means for the stock and the drone services market. GlobeNewswire What ZenaTech announced today How markets and media reacted today (Nov. 11) Stock action at a glance As of early afternoon (approx. 14:39 UTC), ZENA traded around $4.01, with an intraday range
SoFi (SOFI) Becomes First U.S. National Bank to Offer In‑App Crypto Trading; Stock Jumps on Nov. 11, 2025

SoFi (SOFI) Becomes First U.S. National Bank to Offer In‑App Crypto Trading; Stock Jumps on Nov. 11, 2025

What happened SoFi Technologies (NASDAQ: SOFI) today unveiled SoFi Crypto, restoring in‑app crypto trading for its members after a two‑year pause. The phased rollout starts immediately and will expand over the coming weeks. Members can purchase crypto straight from their SoFi Checking or Savings balance and manage digital assets alongside banking, lending and investing in one app. Business Wire SoFi frames the product as “bank‑grade” in compliance, security and oversight, noting the app will offer education and step‑by‑step guidance for first‑time buyers. The company also highlights that crypto assets aren’t FDIC‑ or SIPC‑insured and can be volatile. Business Wire Reuters
Turbo Energy (NASDAQ: TURB) pops on tokenized EaaS pilot with Taurus & Stellar; Spain proof‑of‑concept goes live — Nov. 11, 2025

Turbo Energy (NASDAQ: TURB) pops on tokenized EaaS pilot with Taurus & Stellar; Spain proof‑of‑concept goes live — Nov. 11, 2025

Turbo Energy, S.A. (NASDAQ: TURB) unveiled a blockchain-based pilot to tokenize financing for hybrid solar‑plus‑storage projects, partnering with Switzerland’s Taurus and the Stellar Development Foundation (SDF). The initiative starts with a proof of concept at a Spanish supermarket and could become a new way to fund on‑site, battery‑integrated PPAs using Turbo’s SUNBOX systems. Shares whipsawed on the headline. GlobeNewswire At a glance (today): What Turbo Energy announced Turbo Energy says it will tokenize debt financing for its battery‑integrated PPA model, starting with a supermarket in Spain. Tokens will be issued and managed on the Stellar network, using Taurus‑CAPITAL to handle
11 November 2025
enGene (ENGN) soars after detailing 62% 6‑month complete response in pivotal bladder‑cancer trial; BLA still targeted for 2H 2026

enGene (ENGN) soars after detailing 62% 6‑month complete response in pivotal bladder‑cancer trial; BLA still targeted for 2H 2026

enGene Holdings Inc. (NASDAQ: ENGN) reported fresh preliminary data this morning from the pivotal cohort of its Phase 2 LEGEND trial of detalimogene voraplasmid (formerly EG‑70) in high‑risk, BCG‑unresponsive non‑muscle invasive bladder cancer (NMIBC) with CIS. The readout shows a 62% complete response (CR) at 6 months (n=37), 56% at 3 months (n=62) and 63% CR at any time (n=62) under the trial’s amended protocol—plus a favorable safety profile (42% treatment‑related adverse events; 1.6% dose interruptions; 0.8% discontinuations). The company completed enrollment of 125 patients in the pivotal cohort, above target, and will refine its analysis with FDA input on
NVIDIA (NVDA) Today — Nov. 11, 2025: SoftBank Exits $5.8B Stake, CoreWeave Cuts Outlook, Shares Rebound Near $199 Ahead of Q3 FY26

NVIDIA (NVDA) Today — Nov. 11, 2025: SoftBank Exits $5.8B Stake, CoreWeave Cuts Outlook, Shares Rebound Near $199 Ahead of Q3 FY26

On Tuesday, November 11, 2025, Nvidia (NASDAQ: NVDA) headlines were driven by SoftBank’s surprise sale of its entire Nvidia stake, fresh pressure on key customer CoreWeave after a data‑center delay, and a sharp intraday rebound in NVDA shares as investors look ahead to next week’s earnings. Top developments today NVDA stock snapshot (intraday) As of 14:15:55 UTC on Nov. 11, NVDA traded at $199.05, up ~5.8% on the day (intraday high $198.70 / low $194.72; open $195.00). Why these headlines matter What’s next: Earnings on Wednesday, Nov. 19, 2025 (Q3 FY26) By the numbers (context) Key takeaways for Nov. 11,
1 54 55 56 57 58 233

Stock Market Today

AST SpaceMobile stock bounces late Friday as AT&T plays down Amazon Leo threat and a new 2x short ETF hits tape

AST SpaceMobile stock bounces late Friday as AT&T plays down Amazon Leo threat and a new 2x short ETF hits tape

7 February 2026
AST SpaceMobile shares jumped 9.1% to $101.79 Friday after a volatile week, with 15.9 million shares traded. AT&T said it will use Amazon Leo’s satellite network to reach business customers outside its terrestrial footprint but stated this will not affect its partnership with AST. A new 2x short ETF tied to ASTS, ticker ASTN, began trading on Cboe. AST’s next “BlueBird 7” satellite launch is set for late February on Blue Origin’s New Glenn.
Go toTop